• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

14-3-3蛋白与存活激酶协同作用,通过BH3结构域磷酸化使BAD失活。

14-3-3 proteins and survival kinases cooperate to inactivate BAD by BH3 domain phosphorylation.

作者信息

Datta S R, Katsov A, Hu L, Petros A, Fesik S W, Yaffe M B, Greenberg M E

机构信息

Department of Neurobiology, Harvard Medical School, Boston, Massachusetts 02115, USA.

出版信息

Mol Cell. 2000 Jul;6(1):41-51.

PMID:10949026
Abstract

The Bcl-2 homology 3 (BH3) domain of prodeath Bcl-2 family members mediates their interaction with prosurvival Bcl-2 family members and promotes apoptosis. We report that survival factors trigger the phosphorylation of the proapoptotic Bcl-2 family member BAD at a site (Ser-155) within the BAD BH3 domain. When BAD is bound to prosurvival Bcl-2 family members, BAD Ser-155 phosphorylation requires the prior phosphorylation of Ser-136, which recruits 14-3-3 proteins that then function to increase the accessibility of Ser-155 to survival-promoting kinases. Ser-155 phosphorylation disrupts the binding of BAD to prosurvival Bcl-2 proteins and thereby promotes cell survival. These findings define a mechanism by which survival signals inactivate a proapoptotic Bcl-2 family member, and suggest a role for 14-3-3 proteins as cofactors that regulate sequential protein phosphorylation events.

摘要

促凋亡Bcl-2家族成员的Bcl-2同源结构域3(BH3)介导其与抗凋亡Bcl-2家族成员的相互作用并促进细胞凋亡。我们报告称,生存因子可触发促凋亡Bcl-2家族成员BAD在BAD BH3结构域内的一个位点(Ser-155)发生磷酸化。当BAD与抗凋亡Bcl-2家族成员结合时,BAD Ser-155的磷酸化需要Ser-136先发生磷酸化,Ser-136的磷酸化会募集14-3-3蛋白,这些蛋白随后发挥作用,增加Ser-155对促进生存激酶的可及性。Ser-155的磷酸化会破坏BAD与抗凋亡Bcl-2蛋白的结合,从而促进细胞存活。这些发现确定了一种生存信号使促凋亡Bcl-2家族成员失活的机制,并提示14-3-3蛋白作为辅助因子在调节连续蛋白磷酸化事件中发挥作用。

相似文献

1
14-3-3 proteins and survival kinases cooperate to inactivate BAD by BH3 domain phosphorylation.14-3-3蛋白与存活激酶协同作用,通过BH3结构域磷酸化使BAD失活。
Mol Cell. 2000 Jul;6(1):41-51.
2
BAD Ser-155 phosphorylation regulates BAD/Bcl-XL interaction and cell survival.BAD蛋白的丝氨酸155位点磷酸化调节BAD/Bcl-XL相互作用及细胞存活。
J Biol Chem. 2000 Aug 18;275(33):25865-9. doi: 10.1074/jbc.M004199200.
3
Growth factors inactivate the cell death promoter BAD by phosphorylation of its BH3 domain on Ser155.生长因子通过使细胞死亡促进因子BAD的BH3结构域在丝氨酸155位点磷酸化,从而使其失活。
J Biol Chem. 2000 Aug 11;275(32):25046-51. doi: 10.1074/jbc.M002526200.
4
The proapoptotic BH3-only protein BAD transduces cell death signals independently of its interaction with Bcl-2.促凋亡的仅含BH3结构域的蛋白BAD独立于其与Bcl-2的相互作用来转导细胞死亡信号。
Cell Death Differ. 2002 Nov;9(11):1240-7. doi: 10.1038/sj.cdd.4401097.
5
A chimeric protein induces tumor cell apoptosis by delivering the human Bcl-2 family BH3-only protein Bad.一种嵌合蛋白通过递送人类Bcl-2家族仅含BH3结构域的蛋白Bad来诱导肿瘤细胞凋亡。
Biochemistry. 2005 Mar 15;44(10):4074-82. doi: 10.1021/bi0477687.
6
Induction of Bad-mediated apoptosis by Sindbis virus infection: involvement of pro-survival members of the Bcl-2 family.辛德毕斯病毒感染诱导Bad介导的细胞凋亡:Bcl-2家族促生存成员的参与
Virology. 2002 Jan 20;292(2):258-71. doi: 10.1006/viro.2001.1206.
7
Proapoptotic activity of ITM2B(s), a BH3-only protein induced upon IL-2-deprivation which interacts with Bcl-2.ITM2B(s)的促凋亡活性,ITM2B(s)是一种仅含BH3结构域的蛋白,在白细胞介素-2剥夺时被诱导产生,并与Bcl-2相互作用。
Oncogene. 2002 May 9;21(20):3181-9. doi: 10.1038/sj.onc.1205464.
8
How BAD phosphorylation is good for survival.BAD磷酸化如何对生存有益。
Nat Cell Biol. 1999 Jun;1(2):E33-5. doi: 10.1038/10026.
9
Phosphorylation of BAD at Ser-128 during mitosis and paclitaxel-induced apoptosis.有丝分裂期间及紫杉醇诱导的细胞凋亡过程中BAD蛋白在丝氨酸128位点的磷酸化。
FEBS Lett. 2005 Jun 6;579(14):3090-4. doi: 10.1016/j.febslet.2005.04.067.
10
Vaccinia virus anti-apoptotic F1L is a novel Bcl-2-like domain-swapped dimer that binds a highly selective subset of BH3-containing death ligands.痘苗病毒抗凋亡蛋白F1L是一种新型的类似Bcl-2的结构域交换二聚体,它能结合含BH3结构域的死亡配体中的一个高度选择性亚群。
Cell Death Differ. 2008 Oct;15(10):1564-71. doi: 10.1038/cdd.2008.83. Epub 2008 Jun 13.

引用本文的文献

1
Unlocking the mitochondrial functional code: unraveling the pathogenesis of ovarian cancer and innovative targets to inhibit malignant behavior.解开线粒体功能密码:揭示卵巢癌发病机制及抑制恶性行为的创新靶点。
J Transl Med. 2025 Jul 24;23(1):819. doi: 10.1186/s12967-025-06840-5.
2
Brain proteome changes after intracerebral hemorrhage in aged male and female mice.老年雄性和雌性小鼠脑出血后的脑蛋白质组变化
Neurobiol Dis. 2025 Aug;212:106936. doi: 10.1016/j.nbd.2025.106936. Epub 2025 May 2.
3
Multiple anti-tumor programs are activated by blocking BAD phosphorylation.
通过阻断BAD磷酸化可激活多种抗肿瘤程序。
Oncogene. 2025 May 2. doi: 10.1038/s41388-025-03420-1.
4
Iloprost Concentration-Dependently Attenuates Platelet Function and Apoptosis by Elevating PKA Activity.依洛前列素通过提高蛋白激酶A(PKA)活性,以浓度依赖的方式减弱血小板功能并诱导凋亡。
J Cell Mol Med. 2025 Feb;29(3):e70403. doi: 10.1111/jcmm.70403.
5
Comparing the BAD Protein Interactomes in 2D and 3D Cell Culture Using Proximity Labeling.利用邻近标记比较 2D 和 3D 细胞培养中的 BAD 蛋白互作组。
J Proteome Res. 2024 Aug 2;23(8):3433-3443. doi: 10.1021/acs.jproteome.4c00111. Epub 2024 Jul 3.
6
Phosphoproteomic changes in response to anoxia are tissue-specific in the anoxia-tolerant crucian carp ().耐缺氧鲫鱼中,响应缺氧的磷酸化蛋白质组变化具有组织特异性。
Front Physiol. 2024 May 30;15:1407834. doi: 10.3389/fphys.2024.1407834. eCollection 2024.
7
Defining the heterogeneous molecular landscape of lung cancer cell responses to epigenetic inhibition.定义肺癌细胞对表观遗传抑制反应的异质性分子格局。
bioRxiv. 2024 Sep 24:2024.05.23.592075. doi: 10.1101/2024.05.23.592075.
8
Retinoic acid alleviates the reduction of Akt and Bad phosphorylation and regulates Bcl-2 family protein interactions in animal models of ischemic stroke.视黄酸可减轻缺血性中风动物模型中 Akt 和 Bad 磷酸化的减少,并调节 Bcl-2 家族蛋白相互作用。
PLoS One. 2024 May 16;19(5):e0303213. doi: 10.1371/journal.pone.0303213. eCollection 2024.
9
Kinase signalling adaptation supports dysfunctional mitochondria in disease.激酶信号适应在疾病中支持功能失调的线粒体。
Front Mol Biosci. 2024 Jan 26;11:1354682. doi: 10.3389/fmolb.2024.1354682. eCollection 2024.
10
Concurrent inhibition of pBADS99 synergistically improves MEK inhibitor efficacy in KRAS-mutant pancreatic ductal adenocarcinoma.同时抑制 pBADS99 可协同提高 MEK 抑制剂在 KRAS 突变型胰腺导管腺癌中的疗效。
Cell Death Dis. 2024 Feb 26;15(2):173. doi: 10.1038/s41419-024-06551-7.